ETROLIZUMAB TREATMENT MODULATES MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN'S DISEASE

William Sandborn  1     Julian Panés  2     Franklin Fuh  3     Rich Erickson  3     Rhian Jacob  4     Wenhui Zhang  3     Meina Tang  5     Jacqueline McBride    
1 University of California San Diego,La Jolla,United States
2 Hospital Clínic of Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 Genentech Inc.,South San Francisco,United States
4 Roche Products Limited,Welwyn Garden City,United Kingdom
5 Gen

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing